Table IV.
Multivariate analysis of predictors of distant-recurrence free survival.
| Variable | Preoperative RT (N=49) | Upfront Surgery (N=49) | ||
|---|---|---|---|---|
|
| ||||
| Hazard Ratio (95% CI) | p Value | Hazard Ratio (95% CI) | p Value | |
|
| ||||
| Age | 0.99 (0.96 – 1.01) | 0.27 | 1.01 (0.98 – 1.03) | 0.61 |
|
| ||||
| Tumor Size | 1.07 (0.98 – 1.17) | 0.11 | 1.06 (1.00 – 1.12) | 0.05 |
|
| ||||
| High Grade Histology | 1.67 (0.48 – 5.83) | 0.42 | 5.67 (0.68 – 46.86) | 0.11 |
|
| ||||
| Histology | ||||
| HGUPS* | 0.66 (0.19 – 2.34) | 0.71 | 1.84 (0.53 – 6.43) | 0.05 |
| Leiomyosarcoma | 1.48 (0.01 – 107) | 1.70 (0.38 – 7.49) | ||
| Liposarcoma | 0.40 (0.08 – 1.88) | 0.06 (0.01 – 0.57) | ||
|
| ||||
| Baseline CRP¶ | 0.96 (0.84 – 1.10) | 0.54 | 1.02 (0.96 – 1.08) | 0.49 |
|
| ||||
| Baseline N/L Ratio | 1.04 (0.98 – 1.11) | 0.18 | 1.08 (0.96 – 1.22) | 0.20 |
High grade undifferentiated pleomorphic sarcoma.
C-reactive protein.